
Chest Tube Learning Synthesis and Evaluation Assistant (CheLSEA): A Prospective Observational Trial of an Intelligent Decision Support System.
AI in Chest Tube Management: CheLSEA’s 93% Accuracy in Removal Predictions 📊🤖
Discover the newest research about AI innovations in 🫁 Pulmonology.

AI in Chest Tube Management: CheLSEA’s 93% Accuracy in Removal Predictions 📊🤖

Revolutionary deep learning model predicts acute pulmonary embolism with 93.76% accuracy! 📊💡

Electrodermal activity shows promise in pain assessment, achieving 80% accuracy in detecting breakthrough pain. 📊💡

NICE recommends eight digital tools for asthma management, aiming to improve patient care and reduce health inequalities. 🌬️📱

New biosensor technology may enable lung cancer detection through breath analysis. Early diagnosis could improve patient outcomes. 🌬️🩺

Causal ML identifies patients with sepsis and AKI who benefit from restrictive fluid therapy. 🚑📊 Early AKI reversal rates improved significantly!

Transbronchial cryobiopsy enhances lung disease diagnosis with minimal invasiveness, improving sample quality and reducing complications. 🩺❄️

Revolutionary model achieves 97% accuracy in classifying lung cancer subtypes! 📊🔬 Robust across diverse datasets!

Global AKI: 2 million deaths annually, rising chronic kidney disease risk, and urgent need for equitable care. 🌍💔

AI in CT Detection of COPD: 189 Publications, 37.83% Growth 📈🌍